MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidenceKarl‐Christian Bergmann, Jean Bousquet, S. Arnavielhe et al.|Clinical and Translational Allergy|2018Cited by 139
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthmaP. Schmidt‐grendelmeier, M. Illario, Enrica Menditto et al.|Clinical and Translational Allergy|2019Cited by 131
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world dataBernardo Sousa‐Pinto, N. Pham‐Thi, Ana Sá‐Sousa et al.|Allergy|2022Cited by 63
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK studySanna Toppila‐Salmi, Annabelle Bédard, Xavier Basagaña et al.|Clinical and Translational Allergy|2020Cited by 46
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injuryAlessandro Vercelli, Tiziana Borsello, Silvia Biggi et al.|Cell Death and Disease|2015Cited by 34